These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 19330598

  • 1. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H, Taketani Y.
    Climacteric; 2009 Aug; 12(4):319-28. PubMed ID: 19330598
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H.
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [Abstract] [Full Text] [Related]

  • 3. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 4. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.
    Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
    [Abstract] [Full Text] [Related]

  • 5. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 6. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 9. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ.
    Gynecol Endocrinol; 2001 Oct 20; 15(5):349-58. PubMed ID: 11727357
    [Abstract] [Full Text] [Related]

  • 10. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B, Capp E, Edelweiss MI, de Freitas FM, Wender MC.
    Maturitas; 2009 Jan 20; 62(1):81-4. PubMed ID: 19097715
    [Abstract] [Full Text] [Related]

  • 11. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar 20; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan 20; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 15. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D, Rovati LC, Giacovelli G, Setnikar I, Bottiglioni F.
    Arzneimittelforschung; 2000 Mar 20; 50(3):293-300. PubMed ID: 10758784
    [Abstract] [Full Text] [Related]

  • 16. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec 20; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 17. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
    Guthrie JR, Dennerstein L, Hopper JL, Burger HG.
    Obstet Gynecol; 1996 Sep 20; 88(3):437-42. PubMed ID: 8752255
    [Abstract] [Full Text] [Related]

  • 18. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.
    Obstet Gynecol; 2008 Jun 20; 111(6):1343-51. PubMed ID: 18515518
    [Abstract] [Full Text] [Related]

  • 19. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Jun 20; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 20. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug 20; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.